atracurium has been researched along with Hepatocellular Carcinoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, SW; Ling, X; Wen, L; Yan, B; Zhou, Y | 1 |
| Amann, A; Amberger, A; Fleischer, M; Hoffmann, G; Marth, C; Niedermüller, P; Nigrovic, V; Pühringer, F; Rieder, J | 1 |
2 other study(ies) available for atracurium and Hepatocellular Carcinoma
| Article | Year |
|---|---|
Modulation of mitochondrial permeability transition pore affects multidrug resistance in human hepatocellular carcinoma cells.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Atracurium; bcl-2-Associated X Protein; Carcinoma, Hepatocellular; Cell Line, Tumor; Cisplatin; Cyclosporine; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Flow Cytometry; Humans; Liver Neoplasms; Membrane Potential, Mitochondrial; Microscopy, Confocal; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore | 2010 |
The influence of atracurium, cisatracurium, and mivacurium on the proliferation of two human cell lines in vitro.
Topics: Acetylcysteine; Atracurium; Carboxylic Ester Hydrolases; Carcinoma, Hepatocellular; Cell Count; Cell Division; Cell Line; Endothelium, Vascular; Free Radical Scavengers; Glutathione; Humans; Isoquinolines; Liver Neoplasms; Mivacurium; Neuromuscular Nondepolarizing Agents | 2001 |